Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -166.02% is 16% below its 5-year average of -142.99%, around the middle of its 5-year range (-354.07%–-41.66%).
As of the fiscal period ended Tuesday, June 30, 2026. 87.65% below its 12-month average of -88.47%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q3 FY2026 (2026-06-30): -166.02%.
RETURN ON INVESTED CAPITAL (ROIC)
-166.02%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-88.47%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-156.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-142.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-100.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-109.80%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-87.65%
CURRENT VS 3Y AVG
-6.02%
CURRENT VS 5Y AVG
-16.11%
CURRENT VS 10Y AVG
-64.40%
CURRENT VS 15Y AVG
-51.20%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 610 covered companies
CURRENT VS SECTOR MEDIAN
-393.88%
vs the sector median at left
Edesa Biotech, Inc.
Market Cap
$37.23M
Return on Invested Capital (ROIC)
-166.02%
TTM Avg
-88.47%
3Y Avg
-156.58%
5Y Avg
-142.99%
Market Cap
$37.15M
Return on Invested Capital (ROIC)
-59.10%
TTM Avg
-35.54%
3Y Avg
-33.20%
5Y Avg
-24.47%
Market Cap
$36.48M
Return on Invested Capital (ROIC)
-89.44%
TTM Avg
-27.62%
3Y Avg
-11.28%
5Y Avg
-9.71%
Market Cap
$36.13M
Return on Invested Capital (ROIC)
-171.36%
TTM Avg
-234.34%
3Y Avg
-204.54%
5Y Avg
-189.00%
Market Cap
$38.52M
Return on Invested Capital (ROIC)
1.99%
TTM Avg
-3.38%
3Y Avg
-2.67%
5Y Avg
-1.50%
Market Cap
$38.71M
Return on Invested Capital (ROIC)
-32.18%
TTM Avg
-103.25%
3Y Avg
-133.41%
5Y Avg
-116.42%
Market Cap
$35.53M
Return on Invested Capital (ROIC)
-10.09%
TTM Avg
-4.30%
3Y Avg
-1.90%
5Y Avg
0.50%
Market Cap
$39.63M
Return on Invested Capital (ROIC)
12.67%
TTM Avg
5.06%
3Y Avg
-12.78%
5Y Avg
-16.11%
Market Cap
$35.06M
Return on Invested Capital (ROIC)
-164.58%
TTM Avg
-155.30%
3Y Avg
-94.59%
5Y Avg
-73.98%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | $37.23M | -166.02% | -88.47% | -156.58% | -142.99% |
| iTonic Holdings Ltd. (ITOC)vs › | $37.15M | -59.10% | -35.54% | -33.20% | -24.47% |
| DocGo Inc. (DCGO)vs › | $36.48M | -89.44% | -27.62% | -11.28% | -9.71% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.13M | -171.36% | -234.34% | -204.54% | -189.00% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.52M | 1.99% | -3.38% | -2.67% | -1.50% |
| Incannex Healthcare Limited (IXHL)vs › | $38.71M | -32.18% | -103.25% | -133.41% | -116.42% |
| Accuray Incorporated (ARAY)vs › | $35.53M | -10.09% | -4.30% | -1.90% | 0.50% |
| Nephros, Inc. (NEPH)vs › | $39.63M | 12.67% | 5.06% | -12.78% | -16.11% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.06M | -164.58% | -155.30% | -94.59% | -73.98% |
| Elutia Inc (ELUT)vs › | $34.48M | -79.27% | -43.87% | -333.47% | -212.56% |
ROIC
-166.0%
ROE
-160.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -166.02% |
| 2026-03-31 | -108.00% |
| 2025-12-31 | -59.87% |
| 2025-09-30 | -62.88% |
| 2025-06-30 | -45.61% |
| 2025-03-31 | -41.66% |
| 2024-12-31 | -311.67% |
| 2024-09-30 | -354.07% |
| 2024-06-30 | -292.28% |
| 2024-03-31 | -196.83% |
| 2023-12-31 | -148.88% |
| 2023-09-30 | -125.03% |
| 2023-06-30 | -122.80% |
| 2023-03-31 | -147.36% |
| 2022-12-31 | -149.96% |
| 2022-09-30 | -194.71% |
| 2022-06-30 | -176.87% |
| 2022-03-31 | -124.73% |
| 2021-12-31 | -245.67% |
| 2021-09-30 | -180.42% |
| 2021-06-30 | -127.14% |
| 2021-03-31 | -81.73% |
| 2020-12-31 | -84.28% |
| 2020-09-30 | -69.33% |
| 2020-06-30 | -66.96% |
| 2020-03-31 | -69.66% |
| 2019-12-31 | -115.86% |
| 2019-09-30 | -102.38% |
| 2019-06-30 | -90.08% |
| 2019-03-31 | -65.71% |
| 2018-12-31 | -51.42% |
| 2018-09-30 | -44.99% |
| 2018-06-30 | -42.47% |
| 2018-03-31 | -113.85% |
| 2017-12-31 | -86.39% |
| 2017-09-30 | -70.61% |
| 2017-06-30 | -60.16% |
| 2017-03-31 | -51.76% |
| 2016-12-31 | -46.16% |
| 2016-09-30 | -39.86% |
| 2016-06-30 | -59.26% |
| 2016-03-31 | -47.96% |
| 2015-12-31 | -44.86% |
| 2015-09-30 | -54.20% |
| 2014-08-31 | -43.81% |
| 2014-05-31 | -38.60% |
| 2014-02-28 | -33.98% |
| 2013-11-30 | -28.30% |
| 2013-08-31 | -79.89% |
| 2013-05-31 | -269.33% |
| 2013-02-28 | -591.44% |
| 2012-11-30 | -372.51% |
| 2012-08-31 | -664.40% |
| 2012-05-31 | -239.12% |
| 2012-02-29 | -160.58% |
| 2011-11-30 | -181.81% |
| 2011-08-31 | -155.80% |
| 2011-05-31 | -113.45% |
| 2011-02-28 | -83.93% |
